Free Trial
BATS:ARKG

ARK Genomic Revolution ETF (ARKG) Price, Holdings, & News

ARK Genomic Revolution ETF logo
$32.85 -0.71 (-2.12%)
As of 06/10/2026 04:10 PM Eastern

About ARK Genomic Revolution ETF (BATS:ARKG)

Advanced

Key Stats

Today's Range
$32.83
$34.38
50-Day Range
$26.42
$36.27
52-Week Range
$22.73
$37.30
Volume
1.91 million shs
Average Volume
2.77 million shs
Market Capitalization
$1.47 billion
Assets Under Management
$1.26 billion
Dividend Yield
N/A
Net Expense Ratio
0.75%
Aggregate Rating
Moderate Buy

ETF Overview

ARK Genomic Revolution ETF Expenses

TypeARKGTheme ETFsEquity ETFsBATS ETFsAll ETFs
Management Fee0.75%0.57%0.57%0.59%0.53%
Other Expenses0.00%0.57%0.55%0.45%0.55%
Total Expense0.75%0.73%0.76%0.72%0.73%
Fee Waiver0.00%-0.74%-0.64%-0.40%-0.61%
Net Expense0.75%0.60%0.63%0.65%0.60%
Receive ARKG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ARK Genomic Revolution ETF and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ARKG ETF News Headlines

Glass cube labeled ETF on trading desk with stock charts, symbolizing equal-weight ETF strategy
3 ETFs For the Coming Genomics Revolution (ARKG)
Genomics companies are an exciting frontier in health care, and ETFs can help to diversify to control risk while positioning investors to benefit.
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.tc pixel
AI, Genomics, and CRISPR Signal a New Phase of Biological Innovation
See More Headlines

ARKG ETF - Frequently Asked Questions

ARK Genomic Revolution ETF's stock was trading at $28.9250 at the beginning of 2026. Since then, ARKG shares have increased by 13.6% and is now trading at $32.85.

ARK Genomic Revolution ETF's top institutional investors include Bank of America Corp DE (1.95%), Midwest Financial Partners Investments Inc. (0.47%), Cetera Investment Advisers (0.23%) and Himension Capital Singapore PTE. LTD. (0.19%).

Shares of ARKG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ARK Genomic Revolution ETF investors own include Invesco QQQ (QQQ), Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), AbbVie (ABBV) and PayPal (PYPL).

Fund Details

Issuer
ARK
Fund Name
ARK Genomic Revolution ETF
Tax Classification
Regulated Investment Company
Stock Exchange
BATS
Current Symbol
BATS:ARKG
Inception Date
10/31/2014
Fund Manager
Catherine Wood
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
N/A
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Holdings
35

Fund Statistics

Assets Under Management
$1.26 billion
Average Daily Volume
$2.82 million
Discount/Premium
0.00%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
ARK Investment Management, LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
Foreside Fund Services, LLC
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Jane Street

Options

Optionable
Optionable
Options Volume
158,299
Put Options
80,667
Call Options
77,632

Miscellaneous

Beta
1.62
Creation Unit
50,000
Creation Fee
$500.00
Beginner's Guide To Retirement Stocks Cover

Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Top 10 ARKG Holdings

ARKG Sector Exposure

ARKG Industry Exposure


This page (BATS:ARKG) was last updated on 6/11/2026 by MarketBeat.com Staff.
From Our Partners